IRD
IRD
US67577R1023
Opus Genetics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 14.196.000 10.992.000
29.1%
Cost of Revenue -- --
--
Gross Profit -- --
--
52.795.000 45.066.000
17.2%
Operating Income -38.599.000 -34.074.000
13.3%
Pretax Income -49.591.000 -57.532.000
13.8%
Net Income Common Stockholders -49.591.000 -57.532.000
13.8%
-- --
--
-- --
--
ende